Medicare Opioid Abuse Prevention Measures To Be Enhanced In 2019
Part D plans would need expanded point-of-sale 'edits' for high-dose prescriptions and supply limits for patients new to opioids under proposal in 2019 'call letter' for the Medicare pharmacy benefit.
You may also be interested in...
Agency investigating potential misuse and abuse of gabapentinoids, which CDC had recommended as alternative to opioids, in latest twist to epidemic.
If not reversed by the Biden Administration, demo program that puts plans at increased risk in catastrophic phase would also enhance negotiating leverage for drugs in the protected classes.
Tactic aims to allow incoming Administration to scrutinize so-called ‘midnight rules’ issued in the final days of the Trump Administration before they take effect. Regulators may also solicit stakeholder comments on delayed rules.